GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hunan Warrant Pharmaceutical Co Ltd (SHSE:688799) » Definitions » 3-Year EBITDA Growth Rate

Hunan Warrant Pharmaceutical Co (SHSE:688799) 3-Year EBITDA Growth Rate : 2.70% (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Hunan Warrant Pharmaceutical Co 3-Year EBITDA Growth Rate?

Hunan Warrant Pharmaceutical Co's EBITDA per Share for the three months ended in Mar. 2024 was ¥0.76.

During the past 12 months, Hunan Warrant Pharmaceutical Co's average EBITDA Per Share Growth Rate was 21.20% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 2.70% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 10.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 10 years, the highest 3-Year average EBITDA Per Share Growth Rate of Hunan Warrant Pharmaceutical Co was 54.50% per year. The lowest was 2.70% per year. And the median was 29.60% per year.


Competitive Comparison of Hunan Warrant Pharmaceutical Co's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Hunan Warrant Pharmaceutical Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hunan Warrant Pharmaceutical Co's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hunan Warrant Pharmaceutical Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Hunan Warrant Pharmaceutical Co's 3-Year EBITDA Growth Rate falls into.



Hunan Warrant Pharmaceutical Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Hunan Warrant Pharmaceutical Co  (SHSE:688799) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


Hunan Warrant Pharmaceutical Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Hunan Warrant Pharmaceutical Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Hunan Warrant Pharmaceutical Co (SHSE:688799) Business Description

Traded in Other Exchanges
N/A
Address
Liuyang Biomedical Park, Hunan Province, Changsha, CHN, 410331
Hunan Warrant Pharmaceutical Co Ltd is a pharmaceutical manufacturer. It is engaged in the research and development, production and sales of chemical raw materials, chemical medicine preparations and Chinese medicine preparations.
Executives
Jin Yan Supervisors

Hunan Warrant Pharmaceutical Co (SHSE:688799) Headlines

No Headlines